Literature DB >> 9795455

Altered expression of alpha E beta 7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease.

D Elewaut1, N Van Damme, F De Keyser, D Baeten, P De Paepe, H Van Vlierberghe, H Mielants, C Cuvelier, G Verbruggen, E M Veys, M De Vos.   

Abstract

OBJECTIVE: To compare the expression of adhesion molecules on intestinal intra-epithelial (IEL) and lamina propria T cells (LPL) from ileum and colon, in patients with Crohn's disease (CD) versus healthy controls, with special reference for the alpha E beta 7 integrin.
METHODS: IEL and LPL were obtained from 18 CD patients and 20 controls by enzymatic extraction, and subsequently characterized by flow cytometry for CD3, CD4, CD8, CD25, LFA-1 alpha (CD11a), CD44, alpha 4 and alpha E beta 7 integrin.
RESULTS: In LPL of controls, a decreased CD4/CD8 ratio was noted in ileum compared to colon. This regional difference was accompanied by a higher expression of alpha E beta 7 integrin in ileum versus colon. In LPL from left hemicolon of CD patients, a decreased CD4/CD8 ratio was noted versus controls. alpha E beta 7 expression on T cells of LPL did not discriminate CD from controls. However, an overexpression of this beta 7 integrin member was observed on CD25+ T cell subsets from lamina propria of left hemicolon, in CD versus controls. Moreover, in IEL, profound alterations in alpha E beta 7 integrin were observed in CD, compared to controls. A decreased expression of alpha E beta 7 was noted in IEL of ileum of CD patients. This was also apparent in non-inflamed mucosa.
CONCLUSION: The observed changes of alpha E beta 7 integrin expression in CD patients versus controls are of pathogenic relevance, especially the decreased expression of alpha E beta 7 in IEL of non-inflamed CD mucosa. This may be one of the earliest events in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795455

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  10 in total

1.  Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy.

Authors:  N Van Damme; M De Vos; D Baeten; P Demetter; H Mielants; G Verbruggen; C Cuvelier; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 2.  Alpha E beta 7.

Authors:  P J Kilshaw
Journal:  Mol Pathol       Date:  1999-08

Review 3.  Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.

Authors:  Saskia Thomas; Daniel C Baumgart
Journal:  Inflammopharmacology       Date:  2011-12-20       Impact factor: 4.473

Review 4.  Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.

Authors:  Emilio G Quetglas; Zlatan Mujagic; Simone Wigge; Daniel Keszthelyi; Sebastian Wachten; Ad Masclee; Walter Reinisch
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

5.  Inherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design.

Authors:  Christopher J Tyler; Mauricio Guzman; Luke R Lundborg; Shaila Yeasmin; Tamara Perez-Jeldres; Andres Yarur; Brian Behm; Parambir S Dulai; Derek Patel; Giorgos Bamias; Jesús Rivera-Nieves
Journal:  J Crohns Colitis       Date:  2020-10-05       Impact factor: 9.071

Review 6.  Integrin antagonists as potential therapeutic options for the treatment of Crohn's disease.

Authors:  Leon P McLean; Raymond K Cross
Journal:  Expert Opin Investig Drugs       Date:  2016       Impact factor: 6.206

7.  A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis.

Authors:  Paul J Rutgeerts; Richard N Fedorak; Daan W Hommes; Andreas Sturm; Daniel C Baumgart; Brian Bressler; Stefan Schreiber; John C Mansfield; Marna Williams; Meina Tang; Jennifer Visich; Xiaohui Wei; Mary Keir; Diana Luca; Dimitri Danilenko; Jackson Egen; Sharon O'Byrne
Journal:  Gut       Date:  2012-06-20       Impact factor: 23.059

8.  AlphaE Integrin Expression Is Increased in the Ileum Relative to the Colon and Unaffected by Inflammation.

Authors:  Ryan Ichikawa; Christopher A Lamb; Jeff Eastham-Anderson; Alexis Scherl; Laura Raffals; William A Faubion; Miriam R Bennett; Anna K Long; John C Mansfield; John A Kirby; Mary E Keir
Journal:  J Crohns Colitis       Date:  2018-11-09       Impact factor: 9.071

9.  Intestinal CD103+CD4+ and CD103+CD8+ T-Cell Subsets in the Gut of Inflammatory Bowel Disease Patients at Diagnosis and During Follow-up.

Authors:  Britt Roosenboom; Peter J Wahab; Carolijn Smids; Marcel J M Groenen; Elly van Koolwijk; Ellen G van Lochem; Carmen S Horjus Talabur Horje
Journal:  Inflamm Bowel Dis       Date:  2019-08-20       Impact factor: 5.325

10.  Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by Vedolizumab.

Authors:  Patrizio Scarozza; Irene Marafini; Federica Laudisi; Edoardo Troncone; Heike Schmitt; Marco Vincenzo Lenti; Stefania Costa; Irene Rocchetti; Elena De Cristofaro; Silvia Salvatori; Ludovica Frezzati; Antonio Di Sabatino; Raja Atreya; Markus F Neurath; Emma Calabrese; Giovanni Monteleone
Journal:  J Clin Med       Date:  2020-02-01       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.